Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02954237
What this trial is testing

AMPLATZER™ Cardiac Plug Observational Post-Approval Study

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Abbott Medical Devices 91
Post-approval studies (Phase 4)Study completedNCT05320627
What this trial is testing

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Non-Valvular Atrial Fibrillation
China National Center for Cardiovascular Diseases 150
Not applicableStudy completedNCT05027061
What this trial is testing

Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Who this might be right for
Non-Valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb 11,776
Not applicableStudy completedNCT02792335
What this trial is testing

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 28,000
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableStudy completedNCT01196897
What this trial is testing

Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

Who this might be right for
Atrial Fibrillation
Boston Scientific Corporation 69
Testing effectiveness (Phase 2)Study completedNCT00806624
What this trial is testing

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
Daiichi Sankyo Co., Ltd. 234
Not applicableStudy completedNCT04509193
What this trial is testing

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Who this might be right for
Atrial Fibrillation
Bayer 116,049
Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableStudy completedNCT03119116
What this trial is testing

Use of Direct Oral Anticoagulants in UK

Who this might be right for
Stroke
Bayer 31,336
Testing effectiveness (Phase 2)Study completedNCT03489395
What this trial is testing

A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Raffaele De Caterina 25
Not applicableWithdrawnNCT03508258
What this trial is testing

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

Who this might be right for
Non-valvular Atrial Fibrillation
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT02935855
What this trial is testing

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

Who this might be right for
Diabetes
University of Pavia 300
Not applicableStudy completedNCT02654470
What this trial is testing

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Who this might be right for
Non-valvular Atrial Fibrillation
Boston Scientific Corporation 300
Not applicableTemporarily pausedNCT06168942
What this trial is testing

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

Who this might be right for
Non-valvular Atrial FibrillationStrokeSystemic Embolism
Biosense Webster, Inc. 1,500
Not applicableLooking for participantsNCT07081711
What this trial is testing

Longitudinal Validation of CIRC Technologies

Who this might be right for
Cardiovascular DiseasesHeart FailureIschemic Heart Disease+7 more
The Cleveland Clinic 1,000
Not applicableUnknownNCT03987945
What this trial is testing

Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai

Who this might be right for
Atrial FibrillationLeft Atrial Appendage Occlusion
Shanghai 10th People's Hospital 150
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Not applicableStudy completedNCT02615587
What this trial is testing

Burden of Illness in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 107,532
Not applicableUnknownNCT05498909
What this trial is testing

A Real-world Registry Study of Multidisciplinary Collaborative Diagnosis and Treatment Model for Cardioembolic Stroke

Who this might be right for
Cardioembolic StrokeMultidisciplinary Communication
Xiao Huang 1,200
Next Page